Ostwald ripening in a Pt/SiO2 model catalyst studied by in situ TEM

Sintering of Pt nanoparticles dispersed on a planar SiO(2) support was studied by in situ transmission electron microscopy (TEM). A time-lapsed TEM image series of the Pt nanoparticles, acquired during the exposure to 10 mbar synthetic air at 650 degrees C, reveal that the sintering was governed by the Ostwald ripening mechanism. The in situ TEM images also provide information about the temporal evolution of the Pt particle size distribution and of the growth or decay of the individual nanoparticles. The observed Pt nanoparticle changes compare well with predictions made by mean-field kinetic models for ripening, but deviations are revealed for the time-evolution for the individual nanoparticles. A better description of the individual nanoparticle ripening is obtained by kinetic models that include local correlations between neighboring nanoparticles in the atom-exchange process

Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions

Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors-distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using an unsupervised visualization approach of DNA methylation data, we identified a novel group of tumors (n = 20) that formed a cluster separate from all established CNS tumor types. Molecular analyses revealed ATRX alterations (in 16/16 cases by DNA sequencing and/or immunohistochemistry) as well as potentially targetable gene fusions involving receptor tyrosine-kinases (RTK; mostly NTRK1-3) in all of these tumors (16/16; 100%). In addition, copy number profiling showed homozygous deletions of CDKN2A/B in 55% of cases. Histological and immunohistochemical investigations revealed glioneuronal tumors with isomorphic, round and often condensed nuclei, perinuclear clearing, high mitotic activity and microvascular proliferation. Tumors were mainly located supratentorially (84%) and occurred in patients with a median age of 19 years. Survival data were limited (n = 18) but point towards a more aggressive biology as compared to other glioneuronal tumors (median progression-free survival 12.5 months). Given their molecular characteristics in addition to anaplastic features, we suggest the term glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA) to describe these tumors. In summary, our findings highlight a novel type of glioneuronal tumor driven by different RTK fusions accompanied by recurrent alterations in ATRX and homozygous deletions of CDKN2A/B. Targeted approaches such as NTRK inhibition might represent a therapeutic option for patients suffering from these tumors